Despite recent advances in the scope and breadth of neuromodulation treatments, often times access continues to be limited. Many referring providers are not knowledgeable about the treatments available and many patients, especially those in underserved and rural communities, are statistically undertreated. During this session, we will discuss innovations in education both of neuromodulators, front line providers, and patients in hopes to increase global access to new, groundbreaking neuromodulation therapies.
Upon completion of this educational activity, participants should be able to:
- Outline barriers to access to neuromodulation, including cochlear implants and deep brain stimulation, for patients from rural and underserved communities
- Discuss innovative methods to increase patient knowledge of deep brain stimulation
- Review efforts to increase access to neuromodulation for rural, underserved communities through technologic innovation, including telemedicine and outreach
- Demonstrate the benefit of pipeline programs to increase the reach of our neuromodulation community at large.
- Accelerating Non-Pain Physician Awareness of the Role of Neuromodulation: A Discussion in Healthcare Delivery Science
- Partnering with our Patients to Optimize Outcomes
- Neuromodulation and Neurosurgical Mentorship and Educational Development
- Controversies in Targeted Drug Delivery
- Plenary Session III: Late-Breaking Clinical Trials
Johnathan H. Goree, MD
Stephanie G. Vanterpool, MBA,MD
Parag G. Patil, MD,PHD
Eric G. Cornidez, MD, MBA
Jaleesa Jackson, MD